🇺🇸 FDA
Patent

US 12269860

Compositions and methods comprising engineered chimeric antigen receptor and modulator of CAR

granted A61KA61K2239/11A61K2239/31

Quick answer

US patent 12269860 (Compositions and methods comprising engineered chimeric antigen receptor and modulator of CAR) held by AUTOLUS LIMITED expires Mon Apr 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
AUTOLUS LIMITED
Grant date
Tue Apr 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K2239/11, A61K2239/31, A61K2239/38, A61K2239/47